[Bipolar II disorder].
Horiuchi
Reiko
R
Department of Neuropsychiatry, Faculty of Medicine, University of Yamanashi.
Takeuchi
Junichi
J
D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D002998:Clonazepam / Q000627:therapeutic use; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004359:Drug Therapy, Combination; D020022:Genetic Predisposition to Disease; D006801:Humans; D000077213:Lamotrigine; D008094:Lithium / Q000627:therapeutic use; D012015:Reference Standards; D012306:Risk; D013405:Suicide; D014227:Triazines / Q000627:therapeutic use
D000928:Antidepressive Agents; D018692:Antimanic Agents; D014227:Triazines; D002998:Clonazepam; D008094:Lithium; D000077213:Lamotrigine